BETA INNOV

Beta Innov SAS is a pharmaceutical Research and Development company, created in March 2009 by patient families. Beta Innov is leading two research and development projects which aim to achieve a major therapeutic breakthrough in the treatment of autoimmune diseases and glioblastoma. The scientific approaches adopted are proteomic in immunology and metabolic with regard to glioblastoma. They therefore take on a resolutely innovative character by following insufficiently explored paths.